__________________ Effective Management of Acute and Chronic Pain with Opioid Analgesics, 2nd Edition
2. A licensee who disposes of controlled substances shall: a. maintain records of the disposal for five years from the date of disposal; and b. make the records available for inspection upon request to the Division or its agents. R156-37-607. Surrender of Suspended or Revoked License. 1. A licensee whose license has been restricted, suspended, or revoked shall surrender the license to the Division within 30 days of the effective date of the order. 2. The Division shall consider compliance with this section in evaluating an application for relicensing. R156-37-608. Restricted Applicability - Herbs, Herbal Products, or Food Supplements. Under Section 58-37-2.5, the Division may not apply Title 58, Chapter 37, Utah Controlled Substance Act or Rule R156-37 to restrict citizens or practitioners, regardless of their license status, from the sale or use of herbs, herbal products, or food supplements that are not scheduled as controlled substances by state or federal law. R156-37-609. Electronic Prescriptions for Controlled Substances. 1. Under Subsection 58-37-22(2)(a), a prescribing practitioner or pharmacy experiencing a temporary technical difficulty or electronic failure under Subsection 58-37-22(1)(d) shall document the nature of the technical difficulty or electronic failure on the prescription’s hard copy. 2. A pharmacist who receives a written, oral, or faxed controlled substance prescription is not required to verify that the prescription qualifies for an exemption under this section, and may dispense and deliver medication from an otherwise valid written, oral, or faxed controlled substance prescription. 3. Under Subsection 58-37--22(2)(c), a prescribing practitioner or pharmacy is exempt from the electronic prescription requirements of Section 58-37-22 if: i. (a) the prescribing practitioner is licensed in a jurisdiction other than Utah; and (b) the receiving pharmacy orally confirms the prescription with the prescribing practitioner; iv. the prescribing practitioner and dispensing pharmacy are the same entity; v. the prescription is a Schedule II oral
vii. the prescription drug is under a research protocol; or viii. the prescription is for a medication that requires compounding two or more ingredients; and c. the prescribing practitioner or pharmacy documents the exemption on the prescription’s hard copy.
4. Under Subsection 58-37-22(2)(d), a prescribing practitioner or pharmacy may apply for an extension of time to comply with Subsection 58-37-22(1) by submitting a form to the Division under Section R156-37-610. 5. Under Subsection 58-37-22(2)(e), if an originating pharmacy that receives an electronic controlled substance prescription cannot fill the prescription, the following protocol shall apply: a. if the pharmacy can electronically transmit the prescription, the pharmacy shall: i. contact the ultimate user to determine the pharmacy that is to receive the forward prescription; and ii. document in the automated pharmacy system the identity of the pharmacy receiving the forward prescription; b. if the pharmacy cannot electronically transmit the prescription: i. the pharmacy shall: (a) contact the prescribing practitioner and state the pharmacy cannot fill or transmit the prescription; (b) document in the automated pharmacy system the individual contacted at the prescribing office; and (c) void the prescription; and ii. the prescribing practitioner may electronically transmit a new prescription to a different pharmacy. 6. Under Subsection 58-37-22(2)(f), an electronic prescription shall be issued and dispensed in accordance with 21 CFR Part 1311 (July 26, 2022), which is incorporated by reference. R156-37-610. Electronic Prescribing for Controlled Substance Extension Designation. 1. Under Subsection 58-37-22(2)(d), a prescribing practitioner or pharmacy that cannot comply with Subsection 58-37- 22(1) may apply for an electronic prescribing controlled substance extension on a form provided by the Division, that includes: a. the prescribing practitioner’s or pharmacy’s:
prescription issued in an emergency situation under Section R156-37-605;
vi. the federal Food and Drug
Administration requires the prescription to contain elements that cannot be included in an electronic prescription;
i. name, address, and license number; and ii. current electronic prescribing capabilities;
35
MDUT1125
Powered by FlippingBook